Crossmark

The cardiometabolic safety of dupilumab in atopic dermatitis: A global large-scale cohort study

Published Online: 2025-01-20

Authors

Kridin, Khalaf

Abdelghaffar, Mariam

Ludwig, Ralf J.
License Information

Text and Data Mining valid from 2025-01-20

Version of Record valid from 2025-01-20
More Information

Article History

Received: 3 September 2024

Revised: 3 September 2024

Accepted: 26 November 2024

First Online: 20 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current